Spotlight on biotech in Canada

Market Hunt

English - January 14, 2021 18:13 - 48 minutes - 44.1 MB
Entrepreneurship Business Education academic analysis business education entrepreneurship finance government marketing start ups supply chain Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Refocusing on local Markets

Next Episode: Canada's innovation gap

Venture into the world of corporate biotech in Canada. The year is 2020, the first year of the COVID-19 pandemic. Andrew Casey, President of BIOTECanada weighs in on the industry, government policy, investment trends, and introduces the idea of a Canadian National Health Sciences Fund, a government sponsored fund dedicated to promoting biotech in Canada along with accelerators who help incubate these companies. Awaiting the creation of a foundational Life Sciences company in Canada, Casey tells us how he thinks this company will emerge.

Check out the BIOTECanada Case Study on the International Entrepreneurship Knowledge Hub.

Questions or feedback on our episode? Get in touch with show host Thierry Harris: [email protected]

Guest bio: Andrew Casey

In his role as President & CEO of BIOTECanada Andrew is responsible for the day-to-day operations of the Association. In this capacity, he is the primary spokesperson for Canada’s biotech industry communicating on the industry’s behalf with government, regulators, international bodies, media and the Canadian public. He also ensures BIOTECanada plays a central role in partnership with Government in the development of policy relating to Canada’s biotech sector and the member companies of BIOTECanada.

Episode Links:

In order of appearance:

BIOTECanada

Ie-Knowledge Hub

Aeponyx Video Case Study

Repair, signing with BMS

Zymeworks

Venture Capital Association of Canada

AquaBounty

Okanagan Specialty Fruits

car parts being made out of soy products. Jet fuel being made out of mustard seeds

HBES, the health bio-sciences economic strategy table